Pharmaceuticals

LAMEA Oncology/Anti-cancer drugs Market - Opportunities and Forecasts, 2014 - 2021

  • ALL393743
  • 108 Pages
  • February 2016
  • Pharmaceuticals

Oncology/Anti-cancer drugs are used for treating various cancer types for improving and prolonging a patients survival time. Biological drugs, based on monoclonal antibodies (mAbs) would emerge as a preferred option for treating various cancer types, especially blood cancer (leukaemia). The rising incidence and prevalence of various cancer types, new cancer treatments and growing importance of biological and targeted drug therapies, are driving the market growth of LAMEA oncology/anti-cancer drugs. In addition, increasing demand of anti-cancer drugs for the treatment of ageing population, rising government funds and improved treatment results, are major factors boosting the market growth. However, the high cost involved in new drug development, coupled with threat of failure and adverse effects associated with anti-cancer drugs therapies, would restrain the growth of the LAMEA market. Moreover, accessibility of anti-cancer drugs incurred by high cost, is a major challenge that is expected to further impede the performance of anti-cancer drugs in LAMEA region. Nevertheless, commercialization of advanced therapeutics, such as targeted therapies and immunotherapies (biologic therapies) would reduce the negative influence of restraints and fuel the market growth.



The LAMEA oncology drugs market is segmented into therapeutic modalities, cancer types and countries. Therapeutic modalities segment is further categorized into chemotherapy, targeted therapy, immunotherapy (biologic therapy), hormonal therapy and others. The LAMEA oncology drugs market is expected to reach $17,072.2 million by 2021. Patent expiration of key anti-cancer drugs such as Herceptin (Patent Expiration: EU-2014; US-2019), Erbitux (Patent Expiration: EU-2014; US-2016), Rituxan (Patent Expiration: EU-2013; US-2018) and Avastin (Patent Expiration: EU-2018; US-2019), is expected to boost the growth of cancer biosimilars market by 2021. Further, the biological therapy is the fastest growing segment at a CAGR of 12.2%, throughout the analysis period, on account of high efficacy and target specific action. Moreover, blood cancer drugs market was the largest revenue generating application segment in 2015, owing to the high cost of drugs (immunotherapies), used for the treatment of blood cancer.



Based on countries the LAMEA region is segmented into nine countries named Brazil, Argentina, Nigeria, South Africa, Iraq, Iran, Algeria, Saudi Arabia and Egypt. Brazil dominates the LAMEA market closely followed by Argentina, owing to rising incidence of cancer, high expenditure and gross national income (GNI) of Brazil specifically. In addition, LAMEA market is poised to grow at a promising CAGR of 8.6% during the forecast period. This high growth rate is majorly attributed to the increasing awareness towards advanced therapies, namely immunotherapies and increase in per capita healthcare spending.



The key companies profiled in the report include Amgen Inc., AstraZeneca Plc., Roche Diagnostics, GlaxoSmithKline PLC, Merck & Co., Novartis AG, AbbVie Inc. Sanofi, EIMC United Pharmaceuticals (EUP) and Actavis plc.



KEY BENEFITS:




  • The report provides quantitative analysis of the current market and estimations through 2014-2021 that assists in identifying the prevailing market opportunities.

  • The report helps in understanding the strategies adopted by various companies for gaining market share in the anti-cancer drugs market.

  • The report provides a comprehensive analysis of factors that drive and restrict the growth of the LAMEA anti-cancer drugs market.

  • Market conditions of anti-cancer drugs market across LAMEA region are comprehensively analyzed.

  • Competitive intelligence highlights the business practices followed by leading market players across various geographies.

  • SWOT analysis enables to study the internal environment of the leading companies for strategy formulation.



LAMEA ONCOLOGY/ANTI-CANCER DRUGS MARKET KEY SEGMENTS:



LAMEA oncology/anti-cancer drugs market is segmented into therapeutic modalities, cancer types and countries.




  • By Therapeutic modalities


    • Chemotherapy

    • Targeted Therapy

    • Immunotherapy (Biologic Therapy)

    • Hormonal Therapy

    • Others






  • By Cancer Types


    • Blood Cancer

    • Breast Cancer

    • Gastrointestinal Cancer

    • Respiratory/Lung Cancer

    • Skin Cancer

    • Other Cancers






  • By Countries


    • Brazil

    • Argentina

    • Nigeria

    • South Africa

    • Iraq

    • Iran

    • Algeria

    • Saudi Arabia

    • Egypt

    • Other LAMEA countries




Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Autoimmune Disorders Treatment Asia-Pacific Market Research Report, 2014 - 2020

Graves disease, Multiple sclerosis, Myasthenia gravis, Rheumatoid arthritis, Pernicious anemia and Systemic lupus erythematosus are the most prevalent types of autoimmune disorders. The prevalence of autoimmune diseases is high in ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Histone Deacetylase Inhibitors Market - Analysis, Growth, Global Share, Industry Overview, Trends Opportunities and Forecast 2012 - 2020

Increasing cancer incidences, ongoing research and development on HDAC inhibitors for the treatment of cancer and other diseases, and the potential of HDAC inhibitors to improve the effectiveness of new ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Animal Antimicrobials and Antibiotics Market (Products, Animals, Mode of delivery and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

The term antibiotic or antimicrobial is used for those agents who kill or inhibit the growth of microorganism. The antimicrobials products have significant benefits to the animal and to human ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Orphan Drug Market (Types, Application, Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Orphan drugs are type of pharmaceutical drugs that are used in the treatment of rare genetic diseases or rare medical conditions. The global pharmaceutical drugs market was valued at approximately ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Active Pharmaceutical Ingredient (API) Market - Opportunities and Forecasts, 2014 - 2020

Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Mouth Ulcers Treatment Asia-Pacific Market Research Report, 2013 -2020

A mouth ulcer is a mucosal ulcer that involves sore or open lesion on mucous membrane inside the oral cavity. Generally, mouth ulcers do not require any specific treatment and ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

2017 © Copyright Big Market Research

View Pricing >>